An Actos bladder cancer lawsuit was filed against Takeda Pharmaceutical Company and its partners by a New York resident who alleges he developed bladder cancer after taking Takeda’s type-2 diabetes medication.

Plaintiff Roman B. claims in his Actos bladder cancer lawsuit that he was prescribed Actos in 2007 by his physician as a treatment for his diabetic condition.

He allegedly continued to take Actos for several years until he allegedly suffered bodily injury in the form of cancer tumors in his bladder, leading to “severe and permanent personal injuries, pain, suffering, and mental anguish.” Roman claims in his Actos lawsuit that all his injuries were all directly caused by his consumption of Actos.

Additionally, while the Actos drug label did allegedly contain some product warning, the Actos lawsuit alleges, “the product warnings for Actos in effect during the time period Plaintiff used Actos were vague, incomplete or otherwise inadequate, both substantially and graphically, to alert prescribing physicians as well as Plaintiff [Roman B.] of the bladder cancer risks associated with this drug.”

Roman further claims that had he and his physician been adequately warned that the Actos side effects included an increased risk of bladder cancer, his doctor would likely have not prescribed the drug to the plaintiff and in turn the patient would not have consumed the type-2 diabetes medication.

Because of his Actos bladder cancer condition, Roman has allegedly experienced “severe and personal injuries which are permanent and lasting in nature, physical pain and mental anguish, including diminished enjoyment of life, a risk of future cancer(s), reasonable fear of future cancer, any and all life complications caused by Plaintiff’s bladder cancer, as well as the need for lifelong medical treatment.”

Roman brings several claims against Takeda in this Actos bladder cancer lawsuit, including claims of negligence, failure to warn, defective design, breach of express warranty,  breach of implied warranty, violation of New York general business law, fraud, fraudulent concealment, and loss of consortium for his wife Svetlana K.

This Actos lawsuit is seeking relief for the plaintiff and his family in the form of compensatory damages, punitive and exemplary damages, payment of attorney’s fees, and any other form of relief so deemed just by the court.

The Actos Bladder Cancer Lawsuit is Case No. 1:14-cv-05932-NG-VMS, in the U.S. District Court for the Eastern District of New York.

Actos Bladder Cancer Litigation

Roman is not the only individual to file an Actos bladder cancer lawsuit or join an Actos class action lawsuit. In fact, the number of bladder cancer lawsuits filed against Takeda is so numerous that they have been consolidated into one multidistrict litigation, or MDL, In re: Actos (Pioglitazone) Products Liability Litigation, in a Louisiana federal court.

Aside from the increased risk of bladder cancer, many Actos consumers have reported other side effects related to using the type-2 diabetes mellitus treatment.

These Actos side effects include:

• Chronic kidney disease
• Congestive heart failure
• Liver failure
• Lactic acidosis
• Bone fracture
• Rapid and excessive weight gain
• Difficulty breathing
• Edema (or fluid retention)

During court proceedings for the Actos bladder cancer MDL, it was discovered that Takeda and Lilly knew of the possibility of Actos bladder cancer since 2001, but failed to warn their consumers. Both companies have since been struck with several punitive damages charges in federal court.

Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual Actos lawsuit or Actos class action lawsuit is best for you. [In general, Actos bladder cancer lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.

Learn More